SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three ...

JPMorgan analyst David Adlington lowered the firm’s price target on Alcon (ALC) to CHF 79.60 from CHF 84.30 and keeps an Overweight ...

Alcon ( (ALC)) has released its Q3 earnings. Here is a breakdown of the information Alcon presented to its investors. Alcon, the global leader in eye care, is renowned for its comprehensive range of ...

We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Greetings and welcome to the Alcon third quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal ...

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago ...

Nov 13 (Reuters) - Eye-care group Alcon (ALCC.S), opens new tab cut its 2024 forecasts and missed market expectations for third-quarter sales on Tuesday evening, as a soft U.S. market hit its surgical ...

Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...

For the quarter ended September 2024, Alcon (ALC) reported revenue of $2.43 billion, up 5.6% over the same period last year. EPS came in at $0.81, compared to $0.66 in the year-ago quarter. The ...

--On pace for largest percent decrease since May 9, 2022, when it fell 6.72% --Currently down two consecutive days; down 6.34% over this period --Worst two day stretch since the two days ending Nov.

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

Some key players in the Disposable Contact Lenses Market are The Cooper Companies, Inc., Novartis International AG, Johnson & ...